Cas:604-53-5 binaphthyl manufacturer & supplier

We serve Chemical Name:binaphthyl CAS:604-53-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

binaphthyl

Chemical Name:binaphthyl
CAS.NO:604-53-5
Synonyms:1,1′-Binaphthalene;binaphthyl;EINECS 210-070-6;1,1′-Binaphthalen;1,1′-binaphthyl;binaphthalene;1,1′-Binaphthyl;1,1′-binaphthalene;MFCD00041740
Molecular Formula:C20H14
Molecular Weight:254.325
HS Code:

Physical and Chemical Properties:
Melting point:143-146 °C
Boiling point:405.0±20.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.704
PSA:
Exact Mass:254.109543
LogP:6.44

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,1′-Binaphthalene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00041740 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1′-binaphthyl Use and application,binaphthalene technical grade,usp/ep/jp grade.


Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. binaphthyl manufacturer Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. binaphthyl supplier Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. binaphthyl vendor Compared to white women, Black women are more likely to be diagnosed with breast cancer before age 50 or with estrogen receptor (ER)-negative and triple-negative breast cancer. binaphthyl factory Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule.